NaYF 4 :Yb/Er@Mn 3 O 4 @GOX Nanocomposite for Upconversion Fluorescence Imaging and Synergistic Cascade Cancer Therapy by Apoptosis and Ferroptosis
Small · 2024
DOI: 10.1002/smll.202304438 ↗Kurz gefasst
Fachartikel in der Zeitschrift Small, 2024. Verfasst von Yinyin Chen und 8 weiteren Autor:innen. Beteiligte Einrichtung: College of Agronomy, Sichuan Agricultural University, Chengdu, Sichuan, 611130, China. Hauptthemen laut MEDLINE: Ferroptosis, Nanocomposites, Neoplasms. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 46 Literaturangaben. Gefördert von: Foundation on Sichuan Key Discipline Construction Project of Traditional Chinese Medicine, Foundation on Double-Support Plan of Disciplinary Construction in Sichuan Agricultural University-Innovation Team Projects.
Abstract (Originalsprache)
The cell elimination strategy based on reactive oxygen species (ROS) is a promising method for tumor therapy. However, its efficacy is significantly limited by ROS deficiency caused by H 2 O 2 substrate deficiency and up‐regulation of cellular antioxidant defense induced by high glutathione (GSH) content in tumor cells. To overcome these obstacles, a multifunctional self‐cascaded nanocomposite: glucose oxidase (GOX) loaded NaYF 4 :Yb/Er@Mn 3 O 4 (UC@Mn 3 O 4 , labeled as UCMn) is constructed. Only in tumor microenvironment, it can be specifically activated through a series of cascades to boost ROS production via a strategy of open source (H 2 O 2 self‐supplying ability). The increased ROS can enhance lipid peroxidation and induce tumor cell apoptosis by activating the protein caspase. More importantly, the nanozyme can consume GSH to inhibit glutathione peroxidase 4 (GPX4) activity, which limits tumor cell resistance to oxidative damage and triggers the tumor cell ferroptosis. Therefore, this strategy is expected to overcome the resistance of tumor to oxidative damage and achieve efficient oxidative damage of tumor. Further, degradation of the Mn 3 O 4 layer induced by GSH and acidic environment can promote the fluorescence recovery of UC fluorescent nuclear for tumor imaging to complete efficient integration of diagnosis and treatment for tumor.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Agronomy, Sichuan Agricultural University, Chengdu, Sichuan, 611130, China.
- Qingdao Institute for Theoretical and Computational Sciences, Institute of Frontier and Interdisciplinary Science, Shandong University, Qingdao, Shandong, 266237, China.
- Institute of Animal Nutrition, Sichuan Agricultural University, Chengdu, 611130, China.
- Institute of Molecular Sciences and Engineering, Institute of Frontier and Interdisciplinary Science, Shandong University, Qingdao, Shandong, 266237, China.
- College of Science, Sichuan Agricultural University, Chengdu, Sichuan, 611130, China.
ORCID-Profile: Xianxiang Wang
Förderung
- Foundation on Sichuan Key Discipline Construction Project of Traditional Chinese Medicine
- Foundation on Double-Support Plan of Disciplinary Construction in Sichuan Agricultural University-Innovation Team Projects
Zitieren
APA
Chen, Y., Li, H., Hou, B., Wu, A., Wu, W., Li, C., Wang, H., Chen, D., & Wang, X. (2024). NaYF 4 :Yb/Er@Mn 3 O 4 @GOX Nanocomposite for Upconversion Fluorescence Imaging and Synergistic Cascade Cancer Therapy by Apoptosis and Ferroptosis. Small. https://doi.org/10.1002/smll.202304438
Vancouver
Chen Y, Li H, Hou B, Wu A, Wu W, Li C, et al. NaYF 4 :Yb/Er@Mn 3 O 4 @GOX Nanocomposite for Upconversion Fluorescence Imaging and Synergistic Cascade Cancer Therapy by Apoptosis and Ferroptosis. Small. 2024. doi:10.1002/smll.202304438
BibTeX
@article{Chen2024,
author = {Chen, Yinyin and Li, Haoran and Hou, Baoshan and Wu, Aimin and Wu, Wei and Li, Chunxia and Wang, Hao and Chen, Daiwen and Wang, Xianxiang},
title = {NaYF 4 :Yb/Er@Mn 3 O 4 @GOX Nanocomposite for Upconversion Fluorescence Imaging and Synergistic Cascade Cancer Therapy by Apoptosis and Ferroptosis},
journal = {Small},
year = {2024},
doi = {10.1002/smll.202304438}
}
EUVIMED